Biomet BMET

  1. All
  2. Commentary
  3. Headlines
    1. UPDATE 1-EU to clear Zimmer's $13.4 bln Biomet deal -sources

      Headlines

      Wed, 18 Mar 2015

      BRUSSELS, March 18 (Reuters) - U.S. medical device maker Zimmer is set to secure conditional approval from European Union regulators for its proposed $13.4 billion takeover of rival Biomet , two...

    2. EU regulators to clear Zimmer's $13.4 bln buy of Biomet - sources

      Headlines

      Wed, 18 Mar 2015

      BRUSSELS, March 18 (Reuters) - European Union antitrust regulators are set to give conditional approval to U.S. medical device maker Zimmer's proposed $13.4 billion takeover of rival Biomet , two...

    3. EU regulators set new May 26 deadline for Zimmer's Biomet deal

      Headlines

      Tue, 10 Feb 2015

      BRUSSELS, Feb 10 (Reuters) - European Union antitrust regulators will decide by May 26 whether to approve U.S. medical device maker Zimmer's $13.4 billion bid for rival Biomet after Zimmer modified concessions to allay competition concerns.

    4. Zimmer on Cusp of Closing Biomet Deal; Our Fair Value Estimate Remains Unchanged

      Commentary

      Thu, 29 Jan 2015

      confident that its impending purchase of Biomet will close in the first quarter. We think ..... lines in order to make its purchase of Biomet pass muster with antitrust regulators ..... how the regulators handle the Zimmer- Biomet situation may be instructive for any peer

    5. Acquisition of Volcano Enhances Narrow-Moat Philips' Position in Medical Imaging

      Commentary

      Wed, 17 Dec 2014

      the med tech space, such as Becton Dickinson's acquisition of Carefusion for 3.1 times sales and Zimmer's purchase of Biomet for 4.2 times sales, provide some support to this deal. The Volcano acquisition is in line with Philips' strategy to become

    6. Zimmer Delivers Solid 3Q, but Still Awaits Antitrust Clearance for Biomet Acquisition

      Commentary

      Thu, 23 Oct 2014

      Nonetheless, we still think greater pricing pressure is now a fixture in the post health-care reform world. We still expect the Biomet deal to close in first quarter of 2015, but would be very surprised if the antitrust regulators did not force Zimmer to make

    7. Zimmer Sees Anemic Domestic Demand Offset by Stronger International Markets in 2Q

      Commentary

      Thu, 24 Jul 2014

      its acquisition of midtier competitor Biomet . Antitrust regulators in Europe and the ..... will close, and we continue to include Biomet in our valuation. With quarterly revenue ..... its spine business with the addition of Biomet . There just is not enough high-quality

    8. KKR Reports Solid 2Q; KFN Acquisition Closes, Boosting Recurring Income Stream

      Commentary

      Thu, 24 Jul 2014

      Blackstone's 8.4%, Carlyle's 5%, and the S&P 500's 4.7% increases. Upcoming sales transactions for US Foods and Biomet will generate more incentive income in the next quarter or two. With the completion of the KFN deal, KKR (at the asset manager

    9. “Tax Reform is Impossible – Until it is Inevitable”

      Headlines

      Tue, 22 Jul 2014

      Biomet moves closer to private territory.

    10. Tides Turn for These Orthopedic Firms

      Headlines

      Mon, 30 Jun 2014

      announcement that Zimmer ZMH plans to acquire Biomet , the competitive dynamics in the orthopedic ..... orthopedic surgeons. Zimmer's acquisition of Biomet removes one midtier competitor from the ..... Economic Moat Rating, and the addition of Biomet (which we had also rated as wide moat

    « Prev12345Next »
    Content Partners